These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
455 related articles for article (PubMed ID: 618916)
21. [Comparative study of the melphalan and of the cyclophosphamide in the treatment of Kahler's disease]. Bontoux D; Chenbit D; Delbarre F Therapeutique; 1971 Jan; 47(1):27-32. PubMed ID: 5572915 [No Abstract] [Full Text] [Related]
23. Polymeric (presumed tetrameric) lambda Bence Jones proteinemia without proteinuria in a patient with multiple myeloma. Hom BL Am J Clin Pathol; 1984 Nov; 82(5):627-9. PubMed ID: 6437210 [TBL] [Abstract][Full Text] [Related]
24. Immunocytoma, cancer and other associations of monoclonal gammopathy: a review of 224 cases. Colls BM; Lorier MA N Z Med J; 1975 Oct; 82(549):221-6. PubMed ID: 1059967 [TBL] [Abstract][Full Text] [Related]
25. Myeloma protein kinetics following chemotherapy. McLaughlin P; Alexanian R Blood; 1982 Oct; 60(4):851-5. PubMed ID: 7115956 [TBL] [Abstract][Full Text] [Related]
26. Multiple myeloma. II. The value of melphalan. Bernard DB; Lynch SR; Bothwell TH; Bezwoda WR; Stevens K; Shulman G S Afr Med J; 1974 May; 48(24):1026-8. PubMed ID: 4835772 [No Abstract] [Full Text] [Related]
27. Plasma exchange therapy in rapidly progressive renal failure due to multiple myeloma. Pasquali S; Cagnoli L; Rovinetti C; Rigotti A; Zucchelli P Int J Artif Organs; 1985 Jul; 8 Suppl 2():27-30. PubMed ID: 4055108 [TBL] [Abstract][Full Text] [Related]
28. Myeloma proteins, Bence Jones proteins and normal immunoglobulins in multiple myeloma. Caggiano V; Cuttner J; Solomon A Blood; 1967 Sep; 30(3):265-87. PubMed ID: 6038301 [No Abstract] [Full Text] [Related]
29. [Treatment of myeloma]. Le Chevallier PL Sem Hop; 1971 Jan; 47(4):249-51. PubMed ID: 4322132 [No Abstract] [Full Text] [Related]
30. Comparison of melphalan and prednisone with vincristine, carmustine, melphalan, cyclophosphamide, and prednisone in the treatment of multiple myeloma: results of Eastern Cooperative Oncology Group Study E2479. Oken MM; Harrington DP; Abramson N; Kyle RA; Knospe W; Glick JH Cancer; 1997 Apr; 79(8):1561-7. PubMed ID: 9118039 [TBL] [Abstract][Full Text] [Related]
31. [Bence-Jones proteinuria in multiple sclerosis: a possible indicator of disease activity]. Pascali E; Pezzoli A; Romeo G; Feruglio FS Recenti Prog Med; 1990 Dec; 81(12):797-800. PubMed ID: 2075283 [TBL] [Abstract][Full Text] [Related]
32. [An unusual case of Bence Jones myeloma with unreleased gamma heavy chains in the cytoplasm of the myeloma cells: a close relationship between Bence Jones myeloma and non-secretory myeloma (author's transl)]. Kanoh T; Dohmae N; Uchino H; Sugimoto C; Shimada T Nihon Ketsueki Gakkai Zasshi; 1978 Oct; 41(5):938-44. PubMed ID: 104520 [No Abstract] [Full Text] [Related]
33. Catabolic origin of a Bence Jones protein fragment. Cioli D; Baglioni C J Exp Med; 1968 Sep; 128(3):517-32. PubMed ID: 5666962 [TBL] [Abstract][Full Text] [Related]
34. Detection, significance and treatment of paraprotein in patients presenting with 'idiopathic' proteinuria without myeloma. Mallick NP; Dosa S; Acheson EJ; Delamore IW; McFarlane H; Seneviratne CJ; Williams G Q J Med; 1978 Apr; 47(186):145-75. PubMed ID: 684153 [TBL] [Abstract][Full Text] [Related]
35. Correlation of abnormal immunoglobulin with clinical features of myeloma. Arch Intern Med; 1975 Jan; 135(1):46-52. PubMed ID: 1111470 [TBL] [Abstract][Full Text] [Related]
36. Plasma cell myeloma: response of melphalan-resistant patients to high-dose intermittent cyclophosphamide. Bergsagel DE; Cowan DH; Hasselback R Can Med Assoc J; 1972 Nov; 107(9):851-5. PubMed ID: 4653931 [TBL] [Abstract][Full Text] [Related]
37. Homogeneous immunoglobulins in Ghanaians living in Accra, Ghana. Oyeyinka GO; Ofei V; Maddy SQ; Duah OA; Akafo SK; Aquaye JK; Dosoo DK Afr J Med Med Sci; 2004 Dec; 33(4):311-6. PubMed ID: 15977437 [TBL] [Abstract][Full Text] [Related]
38. A urinary cryo-Bence Jones protein gelling at room temperature. Harris RI; Kohn J Clin Chim Acta; 1974 Jun; 53(2):233-7. PubMed ID: 4841989 [No Abstract] [Full Text] [Related]
39. Multiple myeloma index: verification of a new prognostic approach with evaluation of treatment response. Bettini R; Tonolini M; Bernasconi M Haematologica; 1998 Aug; 83(8):708-13. PubMed ID: 9793254 [TBL] [Abstract][Full Text] [Related]
40. [Membranoproliferative glomerulonephritis as an unusual initial manifestation in a case of plasmacytoma]. Auletta M; Usberti M; Antoniello S; Stanziale P Minerva Med; 1984 Mar; 75(9-10):479-82. PubMed ID: 6709225 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]